An Open-label, Randomized, Fasting, Single-Crossover Study to Compare the Pharmacokinetic Interactions and Safety of YHR2402 Monotherapy and YHR2402 and YHR2403 Co-Administration in Healthy Volunteers
Latest Information Update: 17 Oct 2024
At a glance
- Drugs YHR 2402 (Primary) ; YHR 2403 (Primary) ; Chlorphenamine; Dihydrocodeine; Methylephedrine
- Indications Unspecified
- Focus Pharmacokinetics
- Sponsors Yuhan
- 10 Oct 2024 New trial record